|
E2F3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.269900E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.036820E-01 |
| Normal-vs-Stage2 |
4.508400E-01 |
| Normal-vs-Stage3 |
1.435850E-02 |
| Normal-vs-Stage4 |
1.838050E-02 |
| Stage1-vs-Stage2 |
6.988600E-01 |
| Stage1-vs-Stage3 |
1.191760E-01 |
| Stage1-vs-Stage4 |
1.204630E-01 |
| Stage2-vs-Stage3 |
1.770410E-01 |
| Stage2-vs-Stage4 |
1.589180E-01 |
| Stage3-vs-Stage4 |
7.179200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.702000E-02 |
| Normal-vs-AfricanAmerican |
3.001200E-01 |
| Normal-vs-Asian |
1.760030E-01 |
| Caucasian-vs-AfricanAmerican |
5.451200E-01 |
| Caucasian-vs-Asian |
9.921600E-01 |
| AfricanAmerican-vs-Asian |
6.952600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.962500E-02 |
| Normal-vs-Female |
1.014300E-02 |
| Male-vs-Female |
1.706050E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.026200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.176100E-02 |
| Normal-vs-Age(61-80Yrs) |
5.509900E-02 |
| Normal-vs-Age(81-100Yrs) |
5.209600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.015800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.447800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.667800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.004200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.931400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.703000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.282800E-01 |
| Normal-vs-Grade 2 |
1.368580E-01 |
| Normal-vs-Grade 3 |
4.450200E-02 |
| Normal-vs-Grade 4 |
3.356000E-03 |
| Grade 1-vs-Grade 2 |
7.480800E-01 |
| Grade 1-vs-Grade 3 |
8.767400E-01 |
| Grade 1-vs-Grade 4 |
4.607600E-01 |
| Grade 2-vs-Grade 3 |
5.768000E-01 |
| Grade 2-vs-Grade 4 |
1.776400E-02 |
| Grade 3-vs-Grade 4 |
5.598000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.162000E-02 |
| Normal-vs-ccB subtype |
7.519700E-03 |
| ccA subtype-vs-ccB subtype |
1.279600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.228290E-02 |
| Normal-vs-N1 |
8.162000E-02 |
| N0-vs-N1 |
2.687200E-01 |
|
|
